In a transgenic model of amyotrophic lateral sclerosis, IL-10+ regulatory B cells adoptive transfer therapy could effectively reduce the number of bone marrow-derived macrophages in the central nervous system (33). This evidence concerns the gene IL10 and amyotrophic lateral sclerosis.